4076 Federal Register / Vol. 86, No. 10 / Friday, January 15, 2021 / Notices 

Regulatory Secretariat Division at 202– 

501–4755 or GSARegSec@gsa.gov. 

Instructions: All items submitted 

must cite OMB Control No. 9000–0047, 

Place of Performance. Comments 

received generally will be posted 

without change to http://

www.regulations.gov, including any 

personal and/or business confidential 

information provided. To confirm 

receipt of your comment(s), please 

check www.regulations.gov, 

approximately two-to-three days after 

submission to verify posting. 

FOR FURTHER INFORMATION CONTACT: 

Mahruba Uddowla, Procurement 

Analyst, at telephone 703–605–2868, or 

mahruba.uddowla@gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. OMB control number, Title, and 

any Associated Form(s): 9000–0047, 

Place of Performance. 

B. Need and Uses: This clearance 

covers the information that bidders or 

offerors must submit to comply with the 

following Federal Acquisition 

Regulation (FAR) requirements: 

• 52.214–14, Place of PerformanceSealed Bidding. This FAR provision is 

prescribed for invitation for bids (i.e. 

FAR part 14 procurements) where the 

Government did not specify the place of 

performance. 

• 52.215–6, Place of Performance. 

This FAR provision is prescribed for 

solicitations, when contracting by 

negotiation (i.e. FAR part 15 

procurements), where the Government 

did not specify the place of 

performance. 

Both provisions ask for identical 

information from bidders or offerors: 

Whether or not they intend to use one 

or more plants or facilities located at a 

different address from the address of the 

bidder or offeror as indicated in their 

bid or offer. If the response indicates the 

intention to use plants or facilities 

located at a different location than the 

bidder’s or offeror’s address, the 

provisions require that bidders or 

offerors provide the address(es) of the 

other place(s) of performance, along 

with name and address of the owner 

and operator of such plant or facility (if 

other than the bidder or offeror). 

The contracting officer uses the place 

of performance and the owner of the 

plant or facility to— 

(a) Determine prospective contractor 

responsibility; 

(b) Determine price reasonableness; 

(c) Conduct plant or source 

inspections; and 

(d) Determine whether the 

prospective contractor is a manufacturer 

or a regular dealer. 

C. Annual Burden: 

Respondents/Recordkeepers: 14,188. 

Total Annual Responses: 1,996,197. 

Total Burden Hours: 90,827. 

Obtaining Copies: Requesters may 

obtain a copy of the information 

collection documents from the GSA 

Regulatory Secretariat Division by 

calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. 

Please cite OMB Control No. 9000– 

0047, Place of Performance. 

William F. Clark, 

Director, Office of Government-wide 

Acquisition Policy, Office of Acquisition 

Policy, Office of Government-wide Policy. 

[FR Doc. 2021–00861 Filed 1–14–21; 8:45 am] 

BILLING CODE 6820–EP–P 

GENERAL SERVICES 

ADMINISTRATION 

[OMB Control No. 3090–0293;Docket No. 

2021–0001; Sequence No. 1] 

Information Collection; Reporting and 

Use of Information Concerning 

Integrity and Performance of 

Recipients of Grants and Cooperative 

Agreements 

AGENCY: Office of Technology Strategy/ 

Office of Government-Wide Policy, 

General Services Administration (GSA). 

ACTION: Notice of request for public 

comments regarding an extension to an 

existing OMB clearance. 

SUMMARY: Under the provisions of the 

Paperwork Reduction Act, the 

Regulatory Secretariat Division (MVCB) 

will be submitting to the Office of 

Management and Budget (OMB) a 

request to review and approve an 

extension of the currently approved 

information collection requirement 

concerning the reporting and use of 

information concerning integrity and 

performance of recipients of grants and 

cooperative agreements. 

DATES: Submit comments on or before 

March 16, 2021. 

ADDRESSES: Submit comments 

identified by Information Collection 

3090–0293; Reporting and Use of 

Information Concerning Integrity and 

Performance of Recipients of Grants and 

Cooperative Agreements to http://

www.regulations.gov. 

Submit comments via the Federal 

eRulemaking portal by searching the 

OMB control number 3090–0293. Select 

the link ‘‘Comment Now’’ that 

corresponds with ‘‘Information 

Collection 3090–0293, Reporting and 

Use of Information Concerning Integrity 

and Performance of Recipients of Grants 

and Cooperative Agreements. Follow 

the instructions provided on the screen. 

Please include your name, company 

name (if any), and ‘‘Information 

Collection 3090–0293, Reporting and 

Use of Information Concerning Integrity 

and Performance of Recipients of Grants 

and Cooperative Agreements’’ on your 

attached document. If your comment 

cannot be submitted using 

regulations.gov, call or email the points 

of contact in the FOR FURTHER

INFORMATION CONTACT section of this 

document for alternate instructions. 

Instructions: Please submit comments 

only and cite Information Collection 

3090–0293, Reporting and Use of 

Information Concerning Integrity and 

Performance of Recipients of Grants and 

Cooperative Agreements, in all 

correspondence related to this 

collection. Comments received generally 

will be posted without change to 

regulations.gov, including any personal 

and/or business confidential 

information provided. To confirm 

receipt of your comment(s), please 

check regulations.gov, approximately 

two-to-three business days after 

submission to verify posting. 

FOR FURTHER INFORMATION CONTACT: 

Nancy Goode, Integrated Award 

Environment, GSA, 703–605–2175, or 

via email at nancy.goode@gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. Purpose 

This information collection 

requirement, OMB Control No. 3090– 

0293, currently titled ‘‘Reporting and 

Use of Information Concerning Integrity 

and Performance of Recipients of Grants 

and Cooperative Agreements’’ is 

necessary in order to comply with 

section 872 of the Duncan Hunter 

National Defense Authorization Act of 

2009, Public Law 110–417, as amended 

by Public Law 111–212, hereafter 

referred to as ‘‘the Act.’’ The Duncan 

Hunter National Defense Authorization 

Act of 2009 (Pub. L. 110–417) was 

enacted on October 14, 2008. Section 

872 of this Act required the 

development and maintenance of an 

information system that contains 

specific information on the integrity and 

performance of covered Federal agency 

contractors and grantees. 

The Federal Awardee Performance 

and Integrity Information System 

(FAPIIS) was developed to address these 

requirements. FAPIIS provides users 

access to integrity and performance 

information from the FAPIIS reporting 

module in the Contractor Performance 

Assessment Reporting System (CPARS), 

proceedings information from the Entity 

Management section of the System for 

Award Management (SAM) database, 

and suspension/debarment information 

Federal Register / Vol. 86, No. 10 / Friday, January 15, 2021 / Notices 4077 

from the Performance Information 

section of SAM. 

As stated in 2 CFR 200, Uniform 

Administrative Requirements, Cost 

Principles, and Audit Requirements for 

Federal Awards, the Federal awarding 

agency is required to review information 

available through any OMB-designated 

repositories of government-wide 

eligibility qualification or financial 

integrity information, as appropriate. 

The Federal awarding agency is 

required to review the non-public 

segment of the OMB-designated 

integrity and performance system 

accessible through SAM (currently the 

FAPIIS), prior to making a Federal 

award where the Federal share is 

expected to exceed the simplified 

acquisition threshold (currently 

$250,000), defined in 41 U.S.C. 134, 

over the period of performance. 

For non-federal entities (NFEs), if the 

total value of the NFEs currently active 

grants, cooperative agreements, and 

procurement contracts from all Federal 

awarding agencies exceeds $10,000,000 

for any period of time during the period 

of performance of the Federal award, 

then the NFE must disclose 

semiannually, and maintain the 

currency of information reported to the 

SAM that is made available in the 

designated integrity and performance 

system (currently the FAPIIS) about 

civil, criminal, or administrative 

proceedings, as described in the award 

terms and conditions, for the most 

recent five year period. 

B. Annual Reporting Burden 

Proceedings Screening Question #1 

Respondents: 13,683. 

Respnoses per Respondent: 1. 

Total annual responses: 13,683. 

Hours per response: .1. 

Total response burden hours: 1,368. 

Proceedings Screening Question #2 

Respondents: 1,663. 

Responsed per Respondent: 1. 

Total annual responses: 1,663. 

Hours per response: .1. 

Total response burden hours: 166. 

Proceedings Details 

Respondents: 24. 

Responses per respondent: 2. 

Total annual responses: 48. 

Hours per response: .5. 

Total response burden hours: 24. 

C. Public Comments 

Public comments are particularly 

invited on: Whether our estimate of the 

public burden of this collection of 

information is accurate, and based on 

valid assumptions and methodology; 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and ways in which we can 

minimize the burden of the collection of 

information on those who are to 

respond, through the use of appropriate 

technological collection techniques or 

other forms of information technology. 

Obtaining Copies: Requesters may 

obtain a copy of the information 

collection documents from the GSA 

Regulatory Secretariat Division by 

calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 

Control No. Please cite OMB Control 

No. 3090–0293, Reporting and Use of 

Information Concerning Integrity and 

Performance of Recipients of Grants and 

Cooperative Agreements, in all 

correspondence. 

Beth Anne Killoran, 

Deputy Chief Information Officer. 

[FR Doc. 2021–00867 Filed 1–14–21; 8:45 am] 

BILLING CODE 6820–WY–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Supplemental Evidence and Data 

Request on Interventional Treatments 

for Acute and Chronic Pain: 

Systematic Review 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for Supplemental 

Evidence and Data Submissions 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review on 

Interventional Treatments for Acute and 

Chronic Pain: Systematic Review, which 

is currently being conducted by the 

AHRQ’s Evidence-based Practice 

Centers (EPC) Program. Access to 

published and unpublished pertinent 

scientific information will improve the 

quality of this review. 

DATES: Submission Deadline on or 

before February 16, 2021. 

ADDRESSES: 

Email submissions: epc@ahrq.hhs.gov 

Print submissions: 

Mailing Address: Center for Evidence 

and Practice Improvement, Agency for 

Healthcare Research and Quality. 

ATTN: EPC SEADs Coordinator, 5600 

Fishers Lane, Mail Stop 06E53A, 

Rockville, MD 20857. 

Shipping Address (FedEx, UPS, etc.): 

Center for Evidence and Practice 

Improvement, Agency for Healthcare 

Research and Quality. ATTN: EPC 

SEADs Coordinator, 5600 Fishers Lane, 

Mail Stop 06E77D, Rockville, MD 

20857. 

FOR FURTHER INFORMATION CONTACT: 

Jenae Benns, Telephone: 301–427–1496 

or Email: epc@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the 

Evidence-based Practice Centers (EPC) 

Program to complete a review of the 

evidence for Interventional Treatments 

for Acute and Chronic Pain: Systematic 

Review. AHRQ is conducting this 

systematic review pursuant to Section 

902 of the Public Health Service Act, 42 

U.S.C. 299a. 

The EPC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on Interventional Treatments 

for Acute and Chronic Pain, including 

those that describe adverse events. The 

entire research protocol is available 

online at: https://

effectivehealthcare.ahrq.gov/products/ 

interventional-treatments-pain/protocol. 

This is to notify the public that the 

EPC Program would find the following 

information on Interventional 

Treatments for Acute and Chronic Pain 

helpful: 

■ A list of completed studies that 

your organization has sponsored for this 

indication. In the list, please indicate 

whether results are available on 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

■ For completed studies that do not 

have results on ClinicalTrials.gov, a 

summary, including the following 

elements: Study number, study period, 

design, methodology, indication and 

diagnosis, proper use instructions, 

inclusion and exclusion criteria, 

primary and secondary outcomes, 

baseline characteristics, number of 

patients screened/eligible/enrolled/lost 

to follow-up/withdrawn/analyzed, 

effectiveness/efficacy, and safety results. 

■ A list of ongoing studies that your 

organization has sponsored for this 

indication. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including a study number, the 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion